Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

TCR peptides for MS reported by Connective Therapeutics

Feb. 18, 1997

Yeda discloses peptides for myasthenia gravis

Feb. 18, 1997

Abbott discloses nicotinic cholinergic channel modulators

Feb. 18, 1997

Adenosine kinase inhibitors prepared by Gensia

Feb. 18, 1997

Ampalex trial in AD begins

Feb. 17, 1997

GDNF gene therapy for Parkinson's disease

Feb. 17, 1997

Third launch for Zyprexa

Feb. 17, 1997

Nymox drug candidate for AD to enter phase I

Feb. 14, 1997

HMR synthesizes potent AChE inhibitor

Feb. 14, 1997

Paroxetine inhibits NOS

Feb. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...